Table 1.
Sociodemographic details for the total sample, and for participants with and without a diagnosis of major depression, separately.
| Participants total | Participants non-depressed | Participants depressed | |
|---|---|---|---|
| (N = 212) | (N = 175) | (N = 37) | |
| Sex [male/female] | 81/131 | 62/113 | 19/18 |
| Age [years] (mean ± SD) | 37.14 ± 12.01 | 36.61 ± 13.04 | 39.62 ± 12.73 |
| Smoker (yes/no) | 48/164 | 37/138 | 11/26 |
| BMI [kg/m2] (mean ± SD) | 34.71 ± 13.00 | 35.28 ± 12.25 | 32.02 ± 10.61 |
| Marital status | |||
| married or cohabiting | 53 (25.0%) | 39 (22.3%) | 14 (37.8%) |
| Divorced | 23 (10.8%) | 17 (9.7%) | 6 (16.2%) |
| Widowed | 3 (1.4%) | 2 (1.1%) | 1 (2.7%) |
| Single | 131 (61.8%) | 115 (65.7%) | 16 (43.2%) |
| NA | 1.2% | 2 (1.2%) | 0 |
| Occupational status | |||
| Employed | 106 (50.0%) | 85 (48.6%) | 21 (56.8%) |
| Unemployed | 47 (22.2%) | 38 (21.7%) | 9 (24.3%) |
| Retired | 12 (5.7%) | 8 (4.6%) | 4 (10.8%) |
| Student | 40 (18.9%) | 37 (21.1%) | 3 (8.1%) |
| Homemaker | 4 (1.9%) | 4 (2.3%) | 0 |
| NA | 3 (1.4%) | 3 (1.7%) | 0 |
| Comorbid Disorders (yes) | 87 (41.0%) | 73 (41,7%) | 14 (37,8%) |
| None | 125 (59.0%) | 102 (58.3%) | 23 (62.2%) |
| Arterial hypertension | 50 (23.6%) | 42 (24.0%) | 8 (21.6%) |
| Hypothyreosis | 36 (16.9%) | 31 (17.7%) | 5 (13.5%) |
| Diabetes | 25 (11.8%) | 24 (13.7%) | 1 (2.7%) |
| Obstructive sleep apnea syndrome | 8 (3.8%) | 7 (4.0%) | 1 (2.7%) |
| Asthma | 7 (3.3%) | 6 (4.1%) | 1 (2.7%) |
| Cerebrovascular disorders/Myocardial infarction | 12 (5.7%) | 8 (4.6%) | 4 (10.8%) |
| Medication (yes) | 60 (28.3%) | 52 (29.7%) | 8 (21.6%) |
| None | 152 (71.7%) | 123 (70.3%) | 29 (78.4%) |
| ACE-blocker | 28 (13.2%) | 26 (14.9%) | 2 (5.4%) |
| Beta-blocker | 25 (11.8%) | 22 (12.6%) | 3 (8.1%) |
| Hypoglycaemics | 25 (11.8%) | 24 (13.7%) | 1 (2.7%) |
| AT1-blocker | 18 (8.5%) | 12 (6.9%) | 5 (13.5%) |
| Calcium chanel blocker | 9 (4.2%) | 7 (5.7%) | 2 (5.4%) |
| Statins | 3 (1.4%) | 3 (1.7%) | 0 |